Search clinical trials for: PEEP decrease
Total 0 results
Nothing found
Sponsors and Collaborators
- Pharma Valley Center
- Benazzouz Redouene Sid Ahmed
- Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
- Pedro Julian Flores Moreno
- The PepsiCo Foundation
- Ospedale Garibaldi, Catania
- Fondation Leenaards, Switzerland
- Organkirurgisk afdeling, sygehus lillebælt, Kolding
- Dalian Hospital of Chinese Traditional and Western Medicine
- Tecnalia
- xiaojing wang
- SO Riabilitazione Neuromotoria, IRCCS Fondazione Don Carlo Gnocchi (Firenze) - Francesca Cecchi
- Honda R&D Americas, Inc
- Legal and General
- Roche Diabetes Care Deutschland GmbH
- Sonoma Department of Public Health
- The Dentist
- Xinchen Wang
- Fidmi Medical
- Mahavir Hospital and Research Centre, Hyderabad
- View Full List
Medical Conditions
- Immediate Temporization and Soft Tissue Augmentation Around Delayed Implants
- Marrow Toxic Injury
- Postoperative Wound Healing
- KRAS Mutant Metastatic Non-small Cell Lung Cancer
- Uterine Hyperstimulation
- Foeniculum
- Hair Graying
- Combat Posttraumatic Stess Disorder
- Aminoglycoside Toxicity
- Nurse
- Non-Small Cell Lung Cancer ALK-positive
- Other Complications
- Unstable Cervical Injury
- Active Cancer Treatment
- Progressive IgA Nephropathy
- Neoplasms, Cystic, Mucinous, and Serous
- Oculo-Auriculo-Vertebral-Syndrome
- Osteoarthropathy
- Recurrent Pericarditis
- Anxiety Disorder, Unspecified
- View Full List
Drug Interventions
- Insulin Lispro
- Pediatric-type of chemotherapy (+blinatumomab for B-cell precursor ALL)
- ShA9 Topical Gel
- Tavanic
- GSK1265744 LAP 800mg intramuscular injection
- Surgilube
- Alteplase
- Sufentanil + nalbuphine
- DE-104 ophthalmic solution, high concentration
- Vismodegib
- Bevacizumab [Avastin]
- SPARC1028
- Ropivacaine Intermittent Bolus
- HRS-2329 Tablet
- 0.04 mg/kg of DGPR1008 Injection was administered 24 hours before surgery
- Letermovir 240 mg Oral Tablet
- Chloroquine- P. vivax
- Intravenous immunoglobulin therapy
- Mild dose cannabis
- Anlotinib Hydrochloride
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Argentina
- Contract Research Organizations in Armenia
- Contract Research Organizations in Congo
- Contract Research Organizations in Liberia
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Mexico
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Poland
- Contract Research Organizations in Russia
- Contract Research Organizations in Suriname
- Contract Research Organizations in Uganda
- Contract Research Organizations in United Kingdom
- CRO list by country